News Room

The Covid-19 pandemic exposed vulnerabilities in global supply chains of medical supplies, which stoked public fear over shortages of essential medicines and medical supplies. As the world is focusing on the development of vaccines to combat the latest coronavirus, we shall not lose sight of the delivery of these vaccines, especially when there is a lack of a coordinated medical supply chain in the U.S.

Behind the news about resurging coronavirus cases and the debate about wearing face coverings in the U.S., a global race is underway to develop Covid-19 vaccine to quell the pandemic. As of July 15, 2020, there were 163 vaccines against the coronavirus and 23 of them were undergoing human trials. Before this race ends, we must start thinking about the endgame. The underlying health risks have prompted the U.S. government to promise delivery of 300 million doses of Covid-19 vaccine by January 2021 under Operation Warp Speed.

The pandemic has forced many struggling companies to focus on increasing their bottom line. At the same time, recent protests have strengthened the calls for greater diversity at work. And now, according to three studies, there’s evidence that investors don’t think that organizations can do both at the same time. According to three new studies, there’s a belief that a focus on diversity detracts from efforts to maximize shareholder value (it doesn’t).

North Carolina surpassed 100,000 COVID-19 cases Monday, a somber milestone that comes roughly 140 days after the pandemic first struck. The state Department of Health and Human Services reported 101,046 confirmed cases of COVID-19 Monday, along with an updated death toll of 1,642 people.

The National Collegiate Athletic Association needs to cancel the college-football season. There should be nothing controversial about this statement. After all, Canadian universities canceled fall sports more than a month ago — so has Morehouse College, and so have the Ivies and the entire National Junior College Athletic Association.